{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:12:24Z","timestamp":1787958744083,"version":"build-2784847793"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,20]]},"DOI":"10.7759\/cureus.40690","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T15:55:27Z","timestamp":1687276527000},"source":"Crossref","is-referenced-by-count":2,"title":["Linear IgA Bullous Dermatosis Attributable to the Use of Spironolactone: A Case Report"],"prefix":"10.7759","author":[{"given":"Vineetha","family":"Philip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olushola O","family":"Ogunleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Chukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer J","year":"2019","unstructured":"Lammer J, Hein R, Roenneberg S, Biedermann T, Volz T. Drug-induced linear IgA bullous dermatosis: a case report and review of the literature. Acta Derm Venereol. 2019, 99:5085-15. 10.2340\/00015555-3154","journal-title":"Acta Derm Venereol"},{"key":"ref2","article-title":"Linear IgA bullous dermatosis: a rare clinicopathologic entity with an unusual presentation","volume":"8","author":"Chaudhari S","year":"2015","unstructured":"Chaudhari S, Mobini N. Linear IgA bullous dermatosis: a rare clinicopathologic entity with an unusual presentation. J Clin Aesthet Dermatol. 2015, 8:43-46.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref3","article-title":"Linear IgA bullous dermatosis","volume":"13","author":"Chen S","year":"2013","unstructured":"Chen S, Mattei P, Fischer M, Gay JD, Milner SM, Price LA. Linear IgA bullous dermatosis. Eplasty. 2013, 13:ic49.","journal-title":"Eplasty"},{"key":"ref4","article-title":"Linear IgA bullous dermatosis","year":"2023","unstructured":"Linear IgA bullous dermatosis. UpToDate. Post TW (ed). UpToDate, Waltham, MA; 2023."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00813.x","article-title":"Linear IgA bullous dermatosis","volume":"38","author":"Egan CA","year":"1999","unstructured":"Egan CA, Zone JJ. Linear IgA bullous dermatosis. Int J Dermatol. 1999, 38:818-827. 10.1046\/j.1365-4362.1999.00813.x","journal-title":"Int J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna G","year":"2012","unstructured":"Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis. Clin Dermatol. 2012, 30:38-50. 10.1016\/j.clindermatol.2011.03.008","journal-title":"Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2020.1809759","article-title":"Vancomycin-induced linear IgA bullous dermatosis","volume":"34","author":"Wiggins CJ","year":"2020","unstructured":"Wiggins CJ, Chon SY. Vancomycin-induced linear IgA bullous dermatosis. Proc (Bayl Univ Med Cent). 2020, 34:83-84. 10.1080\/08998280.2020.1809759","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(98)00009-1","article-title":"Drug-induced linear immunoglobulin-A bullous dermatosis","volume":"16","author":"Camilleri M","year":"1998","unstructured":"Camilleri M, Pace JL. Drug-induced linear immunoglobulin-A bullous dermatosis. Clin Dermatol. 1998, 16:389-391. 10.1016\/S0738-081X(98)00009-1","journal-title":"Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00438.x","article-title":"Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid","volume":"24","author":"Ho JC","year":"2007","unstructured":"Ho JC, Ng PL, Tan SH, Giam YC. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid. Pediatr Dermatol. 2007, 24:E40-E43. 10.1111\/j.1525-1470.2007.00438.x","journal-title":"Pediatr Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case-control study","volume":"149","author":"Lloyd-Lavery A","year":"2013","unstructured":"Lloyd-Lavery A, Chi CC, Wojnarowska F, Taghipour K. The associations between bullous pemphigoid and drug use: a UK case-control study. JAMA Dermatol. 2013, 149:58-62. 10.1001\/2013.jamadermatol.376","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3315\/jdcr.2012.1119","article-title":"Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment","volume":"6","author":"Pastuszczak M","year":"2012","unstructured":"Pastuszczak M, Lipko-Godlewska S, Jaworek AK, Wojas-Pelc A. Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment. J Dermatol Case Rep. 2012, 6:117-119. 10.3315\/jdcr.2012.1119","journal-title":"J Dermatol Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01649.x","article-title":"Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"29","author":"Waldman MA","year":"2004","unstructured":"Waldman MA, Black DR, Callen JP. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol. 2004, 29:633-636. 10.1111\/j.1365-2230.2004.01649.x","journal-title":"Clin Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal J","year":"2013","unstructured":"Chanal J, Ingen-Housz-Oro S, Ortonne N, et al.. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol. 2013, 169:1041-1048. 10.1111\/bjd.12488","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.9.1121","article-title":"Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil","volume":"139","author":"Farley-Li J","year":"2003","unstructured":"Farley-Li J, Mancini AJ. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol. 2003, 139:1121-1124. 10.1001\/archderm.139.9.1121","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5070\/D32ts975m4","article-title":"Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children","volume":"16","author":"Kharfi M","year":"2010","unstructured":"Kharfi M, Khaled A, Karaa A, Zaraa I, Fazaa B, Kamoun MR. Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children. Dermatol Online J. 2010, 16:2. 10.5070\/D32ts975m4","journal-title":"Dermatol Online J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15244","article-title":"Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults","volume":"177","author":"Gottlieb J","year":"2017","unstructured":"Gottlieb J, Ingen-Housz-Oro S, Alexandre M, et al.. Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. Br J Dermatol. 2017, 177:212-222. 10.1111\/bjd.15244","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15603","article-title":"Prognostic factors of patients with linear IgA bullous dermatosis","volume":"177","author":"Ishii N","year":"2017","unstructured":"Ishii N. Prognostic factors of patients with linear IgA bullous dermatosis. Br J Dermatol. 2017, 177:16-17. 10.1111\/bjd.15603","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149647-linear-iga-bullous-dermatosis-attributable-to-the-use-of-spironolactone-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:14Z","timestamp":1707509054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149647-linear-iga-bullous-dermatosis-attributable-to-the-use-of-spironolactone-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.40690","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,20]]}}}